The Ross procedure versus repair for treatment of a unicuspid aortic valve in adults
European Journal of Cardio-Thoracic Surgery · 2023
DOI: 10.1093/ejcts/ezad118 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Karen B Abeln und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center, Homburg/Saar, Germany. Hauptthemen laut MEDLINE: Aortic Valve Insufficiency, Pulmonary Valve, Aortic Valve Stenosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVES Aortic stenosis or regurgitation in patients with a unicuspid valve morphology requires interventions early in life. We have performed either primary valve repair or the Ross procedure. The goal of this study was to compare the midterm results of repair and pulmonary autograft replacement. METHODS Between December 1998 and April 2022, a total of 345 patients (77% male; mean age 34 ± 9.7 years) underwent treatment of a unicuspid aortic valve. Patients were excluded if they were <18 years (n = 84) or >54 years (n = 3) at the time of the operation. The remaining cohort was divided into 2 groups: 167 (64%) patients underwent valve repair; 91 (36%) patients underwent pulmonary autograft replacement. The indications for surgery were aortic regurgitation (n = 104), aortic stenosis (n = 45), combined disease (n = 103) and endocarditis (n = 6). Fifty-one patients had root dilatation (>43 mm) with aortic regurgitation (repair n = 23; Ross n = 28). Mean follow-up was 5.9 years (SD: 5 years) [range 0.1–22.3 years]. RESULTS There were 1 early and 3 late deaths; 47 patients required reintervention. Survival at 10 years was 95% in the Ross group and 97% after valve repair (P = 0.769). Freedom from reintervention at 10 years was 98% in the Ross group and 80% after valve repair (P = 0.012). A receiver operating characteristics curve analysis showed a trend towards better durability in patients < 26 years. CONCLUSIONS The ideal treatment of the unicuspid aortic valve remains debatable. Repair of a unicuspid valve can be considered a bridge to pulmonary autograft replacement, at least in younger patients. The appropriate times to replace and to repair require further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center, Homburg/Saar, Germany.
- Department of Cardiovascular Surgery, Kobe Children's Hospital, Kobe, Japan.
ORCID-Profile: Karen B Abeln, Shunsuke Matsushima, Tristan Ehrlich, Christian Giebels, Hans-Joachim Schäfers
Zitieren
APA
Abeln, K. B., Matsushima, S., Ehrlich, T., Giebels, C., & Schäfers, H. J. (2023). The Ross procedure versus repair for treatment of a unicuspid aortic valve in adults. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad118
Vancouver
Abeln KB, Matsushima S, Ehrlich T, Giebels C, Schäfers HJ. The Ross procedure versus repair for treatment of a unicuspid aortic valve in adults. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad118
BibTeX
@article{Abeln2023,
author = {Abeln, Karen B and Matsushima, Shunsuke and Ehrlich, Tristan and Giebels, Christian and Schäfers, Hans-Joachim},
title = {The Ross procedure versus repair for treatment of a unicuspid aortic valve in adults},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
doi = {10.1093/ejcts/ezad118}
}
EUVIMED